Engert A - Search Results

1

Treatment of refractory Hodgkin's lymphoma patients with an iodine-131-labeled murine anti-CD30 monoclonal antibody.

Schnell R, Dietlein M, Staak JO, Borchmann P, Schomaecker K, Fischer T, Eschner W, Hansen H, Morschhauser F, Schicha H, Diehl V, Raubitschek A, Engert A. Schnell R, et al. Among authors: engert a. J Clin Oncol. 2005 Jul 20;23(21):4669-78. doi: 10.1200/JCO.2005.09.098. J Clin Oncol. 2005. PMID: 16034043

2

New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.

Josting A, Franklin J, May M, Koch P, Beykirch MK, Heinz J, Rudolph C, Diehl V, Engert A. Josting A, et al. Among authors: engert a. J Clin Oncol. 2002 Jan 1;20(1):221-30. doi: 10.1200/JCO.2002.20.1.221. J Clin Oncol. 2002. PMID: 11773173

3

Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.

Sieber M, Tesch H, Pfistner B, Rueffer U, Lathan B, Brosteanu O, Paulus U, Koch T, Pfreundschuh M, Loeffler M, Engert A, Josting A, Wolf J, Hasenclever D, Franklin J, Duehmke E, Georgii A, Schalk KP, Kirchner H, Doelken G, Munker R, Koch P, Herrmann R, Greil R, Anselmo AP, Diehl V. Sieber M, et al. Among authors: engert a. J Clin Oncol. 2002 Jan 15;20(2):476-84. doi: 10.1200/JCO.2002.20.2.476. J Clin Oncol. 2002. PMID: 11786577 Clinical Trial.

4

Inhibition of metalloproteinases enhances the internalization of anti-CD30 antibody Ki-3 and the cytotoxic activity of Ki-3 immunotoxin.

Hansen HP, Matthey B, Barth S, Kisseleva T, Mokros T, Davies SJ, Beckett RP, Foelster-Holst R, Lange HH, Engert A, Lemke H. Hansen HP, et al. Among authors: engert a. Int J Cancer. 2002 Mar 10;98(2):210-5. doi: 10.1002/ijc.10182. Int J Cancer. 2002. PMID: 11857410

5

A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma.

Schnell R, Staak O, Borchmann P, Schwartz C, Matthey B, Hansen H, Schindler J, Ghetie V, Vitetta ES, Diehl V, Engert A. Schnell R, et al. Among authors: engert a. Clin Cancer Res. 2002 Jun;8(6):1779-86. Clin Cancer Res. 2002. PMID: 12060617 Clinical Trial.

6

Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma.

Borchmann P, Schnell R, Fuss I, Manzke O, Davis T, Lewis LD, Behnke D, Wickenhauser C, Schiller P, Diehl V, Engert A. Borchmann P, et al. Among authors: engert a. Blood. 2002 Nov 1;100(9):3101-7. doi: 10.1182/blood-2001-12-0295. Blood. 2002. PMID: 12384405 Free article. Clinical Trial.

7

Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia.

Schulz H, Klein SK, Rehwald U, Reiser M, Hinke A, Knauf WU, Aulitzky WE, Hensel M, Herold M, Huhn D, Hallek M, Diehl V, Engert A; German CLL Study Group. Schulz H, et al. Among authors: engert a. Blood. 2002 Nov 1;100(9):3115-20. doi: 10.1182/blood-2002-03-0972. Blood. 2002. PMID: 12384407 Free article. Clinical Trial.

8

Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group.

Rehwald U, Schulz H, Reiser M, Sieber M, Staak JO, Morschhauser F, Driessen C, Rudiger T, Muller-Hermelink K, Diehl V, Engert A; German Hodgkin Lymphoma Study Group (GHSG). Rehwald U, et al. Among authors: engert a. Blood. 2003 Jan 15;101(2):420-4. doi: 10.1182/blood.V101.2.420. Blood. 2003. PMID: 12509381 Free article. Clinical Trial.

9

Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy.

Krause AS, Weihrauch MR, Bode U, Fleischhack G, Elter T, Heuer T, Engert A, Diehl V, Josting A. Krause AS, et al. Among authors: engert a. Leuk Lymphoma. 2002 Nov;43(11):2139-43. doi: 10.1080/1042819021000032953. Leuk Lymphoma. 2002. PMID: 12533039

10

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.

Josting A, Wiedenmann S, Franklin J, May M, Sieber M, Wolf J, Engert A, Diehl V; German Hodgkin's Lymphoma Study Group. Josting A, et al. Among authors: engert a. J Clin Oncol. 2003 Sep 15;21(18):3440-6. doi: 10.1200/JCO.2003.07.160. Epub 2003 Mar 7. J Clin Oncol. 2003. PMID: 12668650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters